The SCID-hu mouse as a model for HIV-1 infection
- PMID: 8515816
- DOI: 10.1038/363732a0
The SCID-hu mouse as a model for HIV-1 infection
Abstract
During normal fetal ontogeny, one of the first organs to harbour CD4-positive cells is the thymus. This organ could therefore be one of the earliest targets infected by human immunodeficiency virus type 1 (HIV-1) in utero. HIV-1-infected cells and pathological abnormalities of the thymus have been seen in HIV-1-infected adults and children, and in some fetuses aborted from infected women. Studies of HIV-1 pathogenesis have been hampered by lack of a suitable animal model system. Here we use the SCID-hu mouse as a model to investigate the effect of virus infection on human tissue. The mouse is homozygous for the severe combined immunodeficiency (SCID) defect. The model is constructed by implanting human fetal liver and thymus under the mouse kidney capsule. A conjoint human organ develops, which allows normal maturation of human thymocytes. After direct inoculation of HIV-1 into these implants, we observed severe depletion of human CD4-bearing cells within a few weeks of infection. This correlated with increasing virus load in the implants. Thus the SCID-hu mouse may be a useful in vivo system for the study of HIV-1-induced pathology.
Similar articles
-
The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.J Immunol. 1995 Jun 15;154(12):6612-23. J Immunol. 1995. PMID: 7759895
-
Divergent effects of chronic HIV-1 infection on human thymocyte maturation in SCID-hu mice.J Immunol. 1995 Jan 15;154(2):907-21. J Immunol. 1995. PMID: 7814892
-
Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.Virology. 1999 Oct 10;263(1):78-88. doi: 10.1006/viro.1999.9869. Virology. 1999. PMID: 10544084
-
SCID-hu mice: a model for studying disseminated HIV infection.Semin Immunol. 1996 Aug;8(4):223-31. doi: 10.1006/smim.1996.0028. Semin Immunol. 1996. PMID: 8883145 Review.
-
The SCID-hu mouse: an in-vivo model for HIV-1 pathogenesis and stem cell gene therapy for AIDS.Semin Immunol. 1996 Aug;8(4):215-21. doi: 10.1006/smim.1996.0027. Semin Immunol. 1996. PMID: 8883144 Review.
Cited by
-
Effects of prostratin on T-cell activation and human immunodeficiency virus latency.J Virol. 2002 Aug;76(16):8118-23. doi: 10.1128/jvi.76.16.8118-8123.2002. J Virol. 2002. PMID: 12134017 Free PMC article.
-
Developmental regulation of P-glycoprotein activity within thymocytes results in increased anti-HIV protease inhibitor activity.J Leukoc Biol. 2011 Oct;90(4):653-60. doi: 10.1189/jlb.0111-009. Epub 2011 Apr 19. J Leukoc Biol. 2011. PMID: 21504949 Free PMC article.
-
Antigen-specific human T-cell responses and T cell-dependent production of human antibodies in a humanized mouse model.Blood. 2008 Apr 15;111(8):4293-6. doi: 10.1182/blood-2007-11-121319. Epub 2008 Feb 12. Blood. 2008. PMID: 18270327 Free PMC article.
-
Regions of human immunodeficiency virus type 1 nef required for function in vivo.J Virol. 1998 Sep;72(9):7032-9. doi: 10.1128/JVI.72.9.7032-7039.1998. J Virol. 1998. PMID: 9696795 Free PMC article.
-
Differential effect of the immunomodulatory hormone somatostatin on replication of human immunodeficiency virus type 1 in CD4+ and CD8+ T lymphocytes.Clin Diagn Lab Immunol. 1995 Mar;2(2):192-8. doi: 10.1128/cdli.2.2.192-198.1995. Clin Diagn Lab Immunol. 1995. PMID: 7697528 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
